In Brief: Genzyme
This article was originally published in The Gray Sheet
Executive Summary
Genzyme: Completes acquisition of surgical products firm Deknatel Snowden Pencer for approximately $250 mil. in cash. Plans for the deal were announced in May ("The Gray Sheet" June 3, p. 7)...